Why This Event Could Clear The Deck For An Alexion Takeover: Analyst

Why This Event Could Clear The Deck For An Alexion Takeover: Analyst

Biotech companies Amgen and Alexion Pharmaceuticals reached an agreement in a patent battle over blockbuster rare-disease drug Soliris. ALXN stock popped Thursday and Friday.